Rapport Therapeutics (NASDAQ:RAPP) Sets New 52-Week High – Time to Buy?
Shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $43.34 and last traded at $43.5650, with a volume of 251378 shares trading hands. The stock had previously closed at $40.39. Wall Street Analysts Forecast Growth Several research analysts […]
2 Jul 14:00 · The Markets Daily